Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
MDGL
#778
Madrigal Pharmaceuticals, Inc. Common Stock
432.000
0
-0.54%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.54%
Changement Mensuel
-14.35%
Evolution sur 6 mois
+1.98%
Changement Annuel
+1.98%
Clôture Précédente
434.360
0
Open
432.000
0
Bid
Ask
Low
432.000
0
High
432.000
0
Volume
139
Marchés
Actions des Marchés US
Soins de Santé
MDGL
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
16.02 M
17.1 M
18.14 M
19.9 M
22.08 M
22.94 M
—
Valuation ratios
Enterprise value
1.73 B
1.41 B
4.85 B
4.41 B
6.71 B
13.16 B
37.01 B
Price to earnings ratio
—
—
-16.57
-11.35
-14.09
-45.32
-123.66
Price to sales ratio
—
—
—
—
36.44
13.63
62.89
Price to cash flow ratio
—
—
21.75
13.08
14.41
68.92
169.55
Price to book ratio
—
—
24.78
10.46
8.7
21.68
29.85
Enterprise value to EBITDA ratio
—
—
—
—
-13.51
—
—
Profitability ratios
Return on assets %
0.7
0.88
0.81
0.58
0.45
0.23
0.25
Return on equity %
0.84
1.23
1.5
0.92
0.62
0.48
0.44
Return on invested capital %
38.24 K
46.1 K
60.8 K
54.38 K
28.26 K
9 549.63
—
Gross margin %
—
—
—
—
96.54
100
396.71
Operating margin %
—
—
—
—
276.39
31.31
138.21
EBITDA margin %
—
—
—
—
-275.78
—
—
Net margin %
—
—
—
—
258.64
30.08
131.22
Liquidity ratios
Quick ratio
—
—
—
—
5.9
3.77
17.4
Current ratio
6.13
3.54
3.12
5.38
6.1
4.01
18.47
Inventory turnover
—
—
—
—
0.18
—
—
Asset turnover
0
0
0
0
0.21
0.83
0.83
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.14
0.18
0.11
0.27
0.75
Long term debt to total equity ratio
—
—
0.25
0.28
0.16
0.56
1.44
Per share metrics
Operating cash flow per share
—
—
13.12
17.35
21.42
8.45
8.54
EBIT per share
—
—
—
—
-23.4
—
—
EBITDA per share
—
—
—
—
-23.35
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
20.94
33.93
43.78
43.84
167.93
Net current asset value per share
—
—
21.09
34.1
48.56
55.53
205.33
Tangible book value per share
—
—
11.52
21.69
35.24
26.54
117.13
Working capital per share
—
—
14.32
27.76
40.6
41.7
157.67
Book value per share
—
—
11.52
21.69
35.46
26.86
118.21
Nouvelles
Madrigal: The Easiest Money May Have Been Made (NASDAQ:MDGL)
Novo Nordisk Stock: Why Wegovy Growth Beats Wall Street Expectations (NYSE:NVO)
H.C. Wainwrightが Madrigal Pharmaceuticals株の投資判断を買い推奨で据え置き
H.C. Wainwright reiterates Madrigal Pharmaceuticals stock rating at buy
Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down
Lam Research, Goldman Sachs among market cap stock movers on Thursday
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call Transcript
Oracle, Deere among market cap stock movers on Thursday
Madrigal 2025年第4四半期決算:Rezdiffraが初年度売上10億ドルに迫るもEPS予想を下回る
Madrigal Q4 2025 slides: Rezdiffra nears $1B in first year sales despite EPS miss
Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates
Madrigal Pharma株、第4四半期決算が予想下回り5%超下落、売上高は予想上回る